Hospor Hospitais Portugueses S.A.

At Hospor Hospitais Portugueses S.A. in Setubal, clinical research in cardiology focuses strongly on cardiovascular diseases, especially heart failure, hypertension, and broader high cardiovascular risk populations. These trials are designed to test new treatment approaches and better understand how to reduce serious heart-related events and improve outcomes for patients with complex cardiac conditions.

• Evaluating therapies for heart failure in patients with preserved or mildly reduced ejection fraction
• Studying treatments aimed at lowering cardiovascular risk and preventing major heart events
• Assessing options for people with hypertension and established heart disease

Overall, this area reflects a clear emphasis on improving treatment effectiveness for patients with advanced or high-risk cardiovascular conditions.

The site also contributes to neoplasm research, with a focus on early breast cancer that is node-positive, estrogen receptor-positive, and HER2-negative. This work is aimed at comparing new treatment strategies with current standard care to help improve long-term cancer control and reduce the chance of recurrence.

• Testing a new therapy against standard endocrine treatment in early breast cancer
• Supporting research in patients with a higher risk of cancer recurrence
• Exploring ways to improve invasive breast cancer-free survival

This oncology portfolio highlights the hospital’s involvement in advancing care for selected breast cancer populations through comparative treatment research.

Research in respiratory tract diseases includes studies in chronic obstructive pulmonary disease, with attention to inflammatory pathways that may influence symptoms and disease control. These trials are intended to evaluate new biologic approaches and improve the management of patients living with chronic lung disease.

• Investigating treatment options for COPD with type 2 inflammation
• Assessing whether new therapies can better control chronic lung inflammation
• Looking for improved ways to support long-term respiratory health

At this Portuguese hospital, respiratory research adds another important dimension to a trial program that spans both heart and lung disease.